Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Knowledge and Use of Over-the-counter Drugs in Italy: An Exploratory Survey-based Study in the General Population

Author(s): Stefania Chiappini*, Franca Ceci, Alessio Mosca, Francesco Di Carlo, Julius Burkauskas, Mauro Pettorruso, Giovanni Martinotti, Amira Guirguis, John M. Corkery, Norbert Scherbaum, Fabrizio Schifano and Massimo Di Giannantonio

Volume 21, Issue 1, 2023

Published on: 06 October, 2022

Page: [133 - 141] Pages: 9

DOI: 10.2174/1570159X20666220714104231

Price: $65

Abstract

Background: During the past decade, the misuse of over-the-counter (OTC) medicines has become a global public health concern, especially among young people. In this study, we aimed to explore the OTC consumption and related misuse in Italy and identify the demographic characteristics of people/individuals involved in this phenomenon, understanding eventual risk factors.

Methods: The study consisted of an anonymous online survey distributed by direct contact and via the Internet between June-November 2021 to the general population living in Italy. Descriptive statistics were reported, and binary regression analyses were performed to identify risk factors for lifetime misuse of OTC. The University of Hertfordshire approved the study (aLMS/SF/UH/02951).

Results: The final sample size was composed of 717 respondents. The sample was mainly represented by female (69.3%) students (39.9%) in the 20-25 years age group (30.0%). Based on the survey responses, study participants were divided into two groups according to the presence/absence of OTC abuse/misuse (127 versus 590), which were compared for possible predictors of OTC diversion. Multivariate regression showed that OTC abuse/misuse was associated with the knowledge of the effects of OTC [odds ratio/OR = 2.711, 95%Confidence Interval/CI 1.794-4.097, p <0.001]. On the contrary, the educational level appeared to be a protective factor [OR = 0.695, 95%CI 0.58–0.94, p = 0.016].

Conclusion: Although, according to our data, the phenomenon of OTC abuse appeared to be limited, increasing attention is needed because of possible underestimation and high-risk outcomes. Preventive strategies, including simplified access to information, may play a key role in limiting OTC misuse.

Keywords: over-the-counter drugs, OTC, drug misuse, drug diversion, survey

« Previous Next »
Graphical Abstract

[1]
Chiappini, S.; Schifano, F. What about “pharming”? Issues regarding the misuse of prescription and over-the-counter drugs. Brain Sci., 2020, 10(10), 736.
[http://dx.doi.org/10.3390/brainsci10100736] [PMID: 33066476]
[2]
Chiappini, S.; Guirguis, A.; Corkery, J.M.; Schifano, F. Misuse of prescription and over-the-counter drugs to obtain illicit highs: How pharmacists can prevent abuse. Pharm. J., 2020, 1-31.
[http://dx.doi.org/10.1211/PJ.2020.20208538]
[3]
Schifano, F.; Chiappini, S.; Miuli, A.; Mosca, A.; Santovito, M.C.; Corkery, J.M.; Guirguis, A.; Pettorruso, M.; Di Giannantonio, M.; Martinotti, G. Focus on over-the-counter drugs’ misuse: A systematic review on antihistamines, cough medicines, and decongestants. Front. Psychiatry, 2021, 12(May), 657397.
[http://dx.doi.org/10.3389/fpsyt.2021.657397] [PMID: 34025478]
[4]
Wright, J.; Bond, C.; Robertson, H.D.; Matheson, C. Changes in over-the-counter drug misuse over 20 years: Perceptions from Scottish pharmacists. J. Public Health (Oxf.), 2016, 38(4), 793-799.
[PMID: 28158745]
[5]
Wazaify, M.; Shields, E.; Hughes, C.M.; McElnay, J.C. Societal perspectives on over-the-counter (OTC) medicines. Fam. Pract., 2005, 22(2), 170-176.
[http://dx.doi.org/10.1093/fampra/cmh723] [PMID: 15710640]
[6]
Hughes, C.M.; McElnay, J.C.; Fleming, G.F. Benefits and risks of self medication. Drug Saf., 2001, 24(14), 1027-1037.
[http://dx.doi.org/10.2165/00002018-200124140-00002] [PMID: 11735659]
[7]
Quispe-Cañari, J.F.; Fidel-Rosales, E.; Manrique, D.; Mascaró-Zan, J.; Huamán-Castillón, K.M.; Chamorro-Espinoza, S.E.; Garayar-Peceros, H.; Ponce-López, V.L.; Sifuentes-Rosales, J.; Alvarez-Risco, A.; Yáñez, J.A.; Mejia, C.R. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharm. J., 2021, 29(1), 1-11.
[http://dx.doi.org/10.1016/j.jsps.2020.12.001] [PMID: 33519270]
[8]
Perrot, S.; Cittée, J.; Louis, P.; Quentin, B.; Robert, C.; Milon, J.Y.; Bismut, H.; Baumelou, A. Self‐medication in pain management: The state of the art of pharmacists’ role for optimal over‐the‐counter analgesic use. Eur. J. Pain, 2019, 23(10), 1747-1762.
[http://dx.doi.org/10.1002/ejp.1459] [PMID: 31349370]
[9]
Gracious, B.; Abe, N.; Sundberg, J. The importance of taking a history of over-the-counter medication use: A brief review and case illustration of “PRN” antihistamine dependence in a hospitalized adolescent. J. Child Adolesc. Psychopharmacol., 2010, 20(6), 521-524.
[http://dx.doi.org/10.1089/cap.2010.0031] [PMID: 21186972]
[10]
NIDA National Institute on Drug Abuse. Research report series; Prescription Drug Abuse, 2011.
[11]
Levine, D.A. ‘Pharming’: The abuse of prescription and over-the-counter drugs in teens. Curr. Opin. Pediatr., 2007, 19(3), 270-274.
[http://dx.doi.org/10.1097/MOP.0b013e32814b09cf] [PMID: 17505185]
[12]
Barrett, S.; Meisner, J.; Stewart, S. What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations. Curr. Drug Abuse Rev., 2008, 1(3), 255-262.
[http://dx.doi.org/10.2174/1874473710801030255] [PMID: 19630724]
[13]
Novak, S.P.; Håkansson, A.; Martinez-Raga, J.; Reimer, J.; Krotki, K.; Varughese, S. Nonmedical use of prescription drugs in the European Union. BMC Psychiatry, 2016, 16(1), 274.
[http://dx.doi.org/10.1186/s12888-016-0909-3] [PMID: 27488186]
[14]
Griffiths, R.R.; Johnson, M.W. Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. J. Clin. Psychiatry, 2005, 66(Suppl. 9), 31-41.
[PMID: 16336040]
[15]
Oyekan, P.J.; Gorton, H.C.; Copeland, C.S. Antihistamine‐related deaths in England: Are the high safety profiles of antihistamines leading to their unsafe use? Br. J. Clin. Pharmacol., 2021, 87(10), 3978-3987.
[http://dx.doi.org/10.1111/bcp.14819] [PMID: 33729599]
[16]
Chiappini, S.; Schifano, F.; Corkery, J.M.; Guirguis, A. Beyond the ‘purple drank’: Study of promethazine abuse according to the european medicines agency adverse drug reaction reports. J. Psychopharmacol., 2021, 35(6), 681-692.
[http://dx.doi.org/10.1177/0269881120959615] [PMID: 33427017]
[17]
Miuli, A.; Stigliano, G.; Lalli, A.; Coladonato, M.; D’Angelo, L.; Esposito, F.; Cappello, C.; Pettorruso, M.; Martinotti, G.; Schifano, F.; Di Giannantonio, M. “Purple Drank” (codeine and promethazine cough syrup): A systematic review of a social phenomenon with medical implications. J. Psychoactive Drugs, 2020, 52(5), 453-462.
[http://dx.doi.org/10.1080/02791072.2020.1797250] [PMID: 32748711]
[18]
Van Hout, M.C.; Norman, I. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies. Int. J. Drug Policy, 2016, 27, 17-22.
[http://dx.doi.org/10.1016/j.drugpo.2015.09.007] [PMID: 26454626]
[19]
Johnston, L.D.; Miech, R.A.; O’Malley, P.M.; Bachman, J.G.; Schulenberg, J.E.; Patrick, M.E. Monitoring the future: National survey results on drug use 1975-2021. Available from: https://deepblue.lib.umich.edu/bitstream/handle/2027.42/171751/mtf
[20]
Berman, J.A.; Setty, A.; Steiner, M.J.; Kaufman, K.R.; Skotzko, C. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids. J. Addict. Dis., 2006, 25(3), 45-48.
[http://dx.doi.org/10.1300/J069v25n03_06] [PMID: 16956868]
[21]
Miller, H.; Panahi, L.; Tapia, D.; Tran, A.; Bowman, J.D. Loperamide misuse and abuse. J. Am. Pharm. Assoc. (Wash. D.C.), 2017, 57(2), S45-S50.
[http://dx.doi.org/10.1016/j.japh.2016.12.079] [PMID: 28189538]
[22]
Schifano, F.; Chiappini, S. Is there such a thing as a ‘lope’ dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports. PLoS One, 2018, 13(10), e0204443.
[http://dx.doi.org/10.1371/journal.pone.0204443] [PMID: 30286103]
[23]
Zaprutko, T.; Koligat, D.; Michalak, M.; Wieczorek, M.; Józiak, M.; Ratajczak, M.; Szydłowska, K.; Miazek, J.; Kus, K.; Nowakowska, E. Misuse of OTC drugs in Poland. Health Policy, 2016, 120(8), 875-881.
[http://dx.doi.org/10.1016/j.healthpol.2016.06.008] [PMID: 27344198]
[24]
Stefania, C.; Andrea, M.; Alessio, M.; Mauro, P.; Amira, G.; Martin, C.J.; Giovanni, M.; Fabrizio, S.; Schifano, F. The benzydamine experience: A systematic review of benzydamine abuse. Curr. Neuropharmacol., 2021, 19(10), 1728-1737.
[http://dx.doi.org/10.2174/1570159X19666210113151136] [PMID: 33441070]
[25]
Hill, D.; McCabe, A.; Paterson, K.; Stuart, J.; Campbell, D. Misuse of over the counter medicines in community pharmacies in Scotland. J. Subst. Use, 2018, 23(1), 7-13.
[http://dx.doi.org/10.1080/14659891.2017.1316783]
[26]
Taylor, S.; Annand, F.; Burkinshaw, P.; Greaves, F.; Kelleher, M.; Knight, J. Dependence and withdrawal associated with some prescribed medicines. An evidence review. Public Heal England, London, 2019, 89-92. Available from: www.facebook.com/PublicHealth England% 0A https://assets.publishing.service.gov.uk/ government/uploads/system/uploads/attachment_data/file/829777/ PHE_PMR_report.pdf
[27]
Fingleton, N.A.; Watson, M.C.; Duncan, E.M.; Matheson, C. Non-prescription medicine misuse, abuse and dependence: A cross-sectional survey of the UK general population. J. Public Health (Oxf.), 2016, 38(4), fdv204.
[http://dx.doi.org/10.1093/pubmed/fdv204] [PMID: 28158728]
[28]
Algarni, M.; Hadi, M.A.; Yahyouche, A.; Mahmood, S.; Jalal, Z. A mixed-methods systematic review of the prevalence, reasons, associated harms and risk-reduction interventions of over-the-counter (OTC) medicines misuse, abuse and dependence in adults. J. Pharm. Policy Pract., 2021, 14(1), 76.
[http://dx.doi.org/10.1186/s40545-021-00350-7] [PMID: 34517925]
[29]
Barrett, R.; Hodgkinson, J. Quality evaluation of community pharmacy blood pressure (BP) screening services: An English cross-sectional survey with geospatial analysis. BMJ Open, 2019, 9(12), e032342.
[http://dx.doi.org/10.1136/bmjopen-2019-032342] [PMID: 31831543]
[30]
Weidmann, A.E.; Cunningham, S.; Gray, G.; Hansford, D.; McLay, J.; Broom, J.; Stewart, D. Over-the-counter orlistat: Early experiences, views and attitudes of community pharmacists in Great Britain. Int. J. Clin. Pharm., 2011, 33(4), 627-633.
[http://dx.doi.org/10.1007/s11096-011-9516-z] [PMID: 21573977]
[31]
Sansgiry, S.; Bhansali, A.; Bapat, S.; Xu, Q. Abuse of over-the-counter medicines: A pharmacist’s perspective. Integr. Pharm. Res. Pract., 2016, 6, 1-6.
[http://dx.doi.org/10.2147/IPRP.S103494] [PMID: 29354545]
[32]
Abraham, O. Chmielinski, J. Adolescents’ misuse of over-the-counter medications: The need for pharmacist-led intervention. Innov. Pharm., 2018, 9(3), 4.
[http://dx.doi.org/10.24926/iip.v9i3.979] [PMID: 34007709]
[33]
Chiappini, S.; Guirguis, A.; John, A.; Corkery, J.M.; Schifano, F. COVID-19: The hidden impact on mental health and drug addiction. Front. Psychiatry, 2020, 11, 767.
[http://dx.doi.org/10.3389/fpsyt.2020.00767] [PMID: 32848937]
[34]
UNODC. World drug report 2021-covid-19 and drugs: Impact outlook. United Nat. Vienna, 2021. Available from: https://www.unodc.org/res/wdr2021/field/WDR21_Booklet_5.pdf
[35]
National Institute on Drug Abuse. Misuse of prescription drugs research report; , 2020, pp. 1-29. Available from: https://www.drugabuse.gov/publications/research-reports/misuseprescription- drugs/what-scope-prescription-drug-misuse
[36]
Martinotti, G.; Alessi, M.C.; Di Natale, C.; Sociali, A.; Ceci, F.; Lucidi, L.; Picutti, E.; Di Carlo, F.; Corbo, M.; Vellante, F.; Fiori, F.; Tourjansky, G.; Catalano, G.; Carenti, M.L.; Incerti, C.C.; Bartoletti, L.; Barlati, S.; Romeo, V.M.; Verrastro, V.; De Giorgio, F.; Valchera, A.; Sepede, G.; Casella, P.; Pettorruso, M.; di Giannantonio, M. Psychopathological burden and quality of life in substance users during the covid-19 lockdown period in Italy. Front. Psychiatry, 2020, 11(September), 572245.
[http://dx.doi.org/10.3389/fpsyt.2020.572245] [PMID: 33101086]
[37]
Brusa, P.; Allais, G.; Scarinzi, C.; Baratta, F.; Parente, M.; Rolando, S.; Gnavi, R.; Spadea, T.; Costa, G.; Benedetto, C.; Mana, M.; Giaccone, M.; Mandelli, A.; Manzoni, G.C.; Bussone, G. Self-medication for migraine: A nationwide cross-sectional study in Italy. PLoS One, 2019, 14(1), e0211191.
[http://dx.doi.org/10.1371/journal.pone.0211191] [PMID: 30673780]
[38]
Ingrasciotta, Y.; Sultana, J.; Giorgianni, F.; Menditto, E.; Scuteri, A.; Tari, M.; Tari, D.U.; Basile, G.; Trifiro’, G. Analgesic drug use in elderly persons: A population-based study in Southern Italy. PLoS One, 2019, 14(9), e0222836.
[http://dx.doi.org/10.1371/journal.pone.0222836] [PMID: 31536588]
[39]
Navaro, M.; Vezzosi, L.; Santagati, G.; Angelillo, I.F. Knowledge, attitudes, and practice regarding medication use in pregnant women in Southern Italy. PLoS One, 2018, 13(6), e0198618.
[http://dx.doi.org/10.1371/journal.pone.0198618] [PMID: 29920515]
[40]
Otto, M.H.; Pillarella, C.; Jommi, C. The economic impact of a switch from prescription-only to nonprescription drugs in Italy. Front. Pharmacol., 2018, 9(OCT), 1069.
[http://dx.doi.org/10.3389/fphar.2018.01069] [PMID: 30386233]
[41]
ICH. Meddra ® term selection: Points to consider. ich-endorsed guide for MedDRA users. London, 2014, pp. 1-49.
[42]
European Monitoring Centre for Drugs and Drug Addiction. Non-medical use of medicines: Health and social responses, 2021. Available from: https://www.emcdda.europa.eu/publications/mini-guides/non-medical-use-of-medicines-health-and-social-responses_en
[43]
NIDA National Institute on Drug Abuse. The science of drug use and addiction: The basics | NIDA archives. Available from: https://archives.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics
[44]
National Collaborating Centre for Mental Health (UK). 2008. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53217/
[45]
Schifano, F.; Napoletano, F.; Chiappini, S.; Guirguis, A.; Corkery, J.M.; Bonaccorso, S.; Ricciardi, A.; Scherbaum, N.; Vento, A. New/emerging psychoactive substances and associated psychopathological consequences – Corrigendum. Psychol. Med., 2021, 51(1), 43.
[http://dx.doi.org/10.1017/S003329171900254X] [PMID: 31511097]
[46]
Huang, B.; Dawson, D.A.; Stinson, F.S.; Hasin, D.S.; Ruan, W.J.; Saha, T.D.; Smith, S.M.; Goldstein, R.B.; Grant, B.F. Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry, 2006, 67(7), 1062-1073.
[http://dx.doi.org/10.4088/JCP.v67n0708] [PMID: 16889449]
[47]
Faugier, J.; Sargeant, M. Sampling hard to reach populations. J. Adv. Nurs., 1997, 26(4), 790-797.
[http://dx.doi.org/10.1046/j.1365-2648.1997.00371.x] [PMID: 9354993]
[48]
European Commission, Directorate-General for Research & Innovation. Horizon 2020 programme - Guidance How to complete your ethics self-assessment V6.1. Eur Comm Dir Res Innov, 2019. 43. Available from: http://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/ethics/h2020_hi_ethics-selfassess_ en.pdf
[49]
Casati, A.; Sedefov, R.; Pfeiffer-Gerschel, T. Misuse of medicines in the European Union: A systematic review of the literature. Eur. Addict. Res., 2012, 18(5), 228-245.
[http://dx.doi.org/10.1159/000337028] [PMID: 22572594]
[50]
Colomer-Pérez, N.; Chover-Sierra, E.; Navarro-Martínez, R.; Andriusevičienė, V.; Vlachou, E.; Cauli, O. Alcohol and drug use in european university health science students: Relationship with selfcare ability. Intern journ env res publ health, 2019, 16(24), 5042.
[http://dx.doi.org/10.3390/ijerph16245042]
[51]
Substance Abuse and Mental Health Services Administration (SAMHSA). 2020 National Survey of Drug Use and Health (NSDUH) releases. 2020. Available from: https://www.samhsa. gov/data/release/2020-national-survey-drug-use-and
[52]
Lessenger, J.E.; Feinberg, S.D. Abuse of prescription and over-the-counter medications. J. Am. Board Fam. Med., 2008, 21(1), 45-54.
[http://dx.doi.org/10.3122/jabfm.2008.01.070071] [PMID: 18178702]
[53]
Cooper, R.J. Over-the-counter medicine abuse – a review of the literature. J. Subst. Use, 2013, 18(2), 82-107.
[http://dx.doi.org/10.3109/14659891.2011.615002] [PMID: 23525509]
[54]
Cooper, R.J. ‘I can’t be an addict. I am.’ Over-the-counter medicine abuse: A qualitative study. BMJ Open, 2013, 3(6), e002913.
[http://dx.doi.org/10.1136/bmjopen-2013-002913] [PMID: 23794565]
[55]
Schifano, F.; Chiappini, S.; Miuli, A.; Corkery, J.M.; Scherbaum, N.; Napoletano, F.; Arillotta, D.; Zangani, C.; Catalani, V.; Vento, A.; Pettorruso, M.; Martinotti, G.; Massimo, D.G.; Guirguis, A. New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Exp. Neurol., 2021, 339(February), 113638.
[http://dx.doi.org/10.1016/j.expneurol.2021.113638] [PMID: 33571533]
[56]
Schaffer, A.L.; Cairns, R.; Brown, J.A.; Gisev, N.; Buckley, N.A.; Pearson, S.A. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine. Med. J. Aust., 2020, 212(7), 321-327.
[http://dx.doi.org/10.5694/mja2.50552] [PMID: 32200566]
[57]
Food and Drug Administration (FDA). FDA drug safety communication: FDA limits packaging for anti-diarrhea medicine loperamide (Imodium) to encourage safe use., 2019. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-limits-packaging-anti-diarrhea-medicine-loperamide-imodium-encourage-safe-use
[58]
Calamusa, A.; Di Marzio, A.; Cristofani, R.; Arrighetti, P.; Santaniello, V.; Alfani, S.; Carducci, A. Factors that influence Italian consumers’ understanding of over-the-counter medicines and risk perception. Patient Educ. Couns., 2012, 87(3), 395-401.
[http://dx.doi.org/10.1016/j.pec.2011.10.003] [PMID: 22119713]
[59]
Ford, J.A.; Pomykacz, C.R.; Ortiz, K.; McCabe, S.E.; Schepis, T.S. Educational attainment and prescription drug misuse: The importance of push and pull factors for dropping out. J. Crim. Justice, 2020, 66, 101636.
[http://dx.doi.org/10.1016/j.jcrimjus.2019.101636] [PMID: 32863457]
[60]
National Institute on Alcohol Abuse and Alcoholism (NIAAA). Harmful Interactions- mixing alcohol with medicines. NIH Publ No 13–5329, 2014. Available from: https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/harmful-interactions-mixing-alcohol-with-medicines
[61]
NIDA National Institute on Drug Abuse. How can prescription drug misuse be prevented? [cited 2022 Sept 27 Available from: https://nida.nih.gov/publications/research-reports/misuse-prescription-drugs/how-can-prescription-drug-misuse-be-prevented
[62]
National Health System (NHS). Prescribing of medicines that are available for purchase (Self-Care). 2020. Available from: https://www.thurrockccg.nhs.uk/about-us/document-library/medicines-management/position-statements/4382-medicines-that-are-available-for-purchase-over-the-counter-may-2020/file

Rights & Permissions Print Cite
Article Metrics
1
© 2025 Bentham Science Publishers | Privacy Policy